Ameresco, Inc.
CFO turnover at Fortune 500 and S&P 500 companies is projected to reach 18.3% in 2026, the highest since 2020. Key CFO changes include AT&T, Caterpillar, Oracle, Nike, and Pfizer. The average age of new CFOs is projected to be 48, down from 52 in 2025. Notable appointments include GE HealthCare, Baxter International, and Ameresco.
Ameresco (AMRC) shares fell 9.3% to $22.98 amid market volatility, with a 24% drop over six months. The company reaffirmed 2026 sales targets of $2B-$2.2B and adjusted EBITDA of $250M-$270M. The CFO's departure and insider purchases totaling over $1M were noted. Q2 2026 revenue increased 9.14% to $515.5M. Analysts' price targets range from $28 to $59.
Ameresco's CFO, Mark Chiplock, will resign effective September 25, 2026. The company's stock has declined 9.78% over five days and 17.60% year-to-date. Ameresco has received various ratings based on valuation, earnings revisions, and visibility.
Over the past 7 days, alphai's AI scored 9 news stories mentioning AMRC (Ameresco, Inc.). Coverage has skewed bearish: 0 bullish, 6 neutral, and 3 bearish.
Recent AMRC coverage spans corporate actions, financial news and macro economy.
In the last 30 days, AMRC insiders filed 4 SEC Form 4 transactions — 4 purchases ($1.2M) and no sales. The most active reporter was Sakellaris George P, Chief Executive Officer, with 3 filings.
Leadership change amid transformation period.
Potential short-term volatility and medium-term execution risk.
Potential short-term stock volatility as investors reassess leadership and financial oversight.
The resignation may affect governance perception but has limited immediate financial impact.
The CFO departure may create short‑term uncertainty and could affect financial reporting and capital allocation.
alphai scores every news story that mentions AMRC with an AI model for sentiment and relevance, and aggregates insider trades from Ameresco, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CFO turnover at Fortune 500 and S&P 500 companies is projected to reach 18.3% in 2026, the highest since 2020. Key CFO changes include AT&T, Caterpillar, Oracle, Nike, and Pfizer. The average age of new CFOs is projected to be 48, down from 52 in 2025. Notable appointments include GE HealthCare, Baxter International, and Ameresco.
5 min readAmeresco (AMRC) shares fell 9.3% to $22.98 amid market volatility, with a 24% drop over six months. The company reaffirmed 2026 sales targets of $2B-$2.2B and adjusted EBITDA of $250M-$270M. The CFO's departure and insider purchases totaling over $1M were noted. Q2 2026 revenue increased 9.14% to $515.5M. Analysts' price targets range from $28 to $59.
2 min readAmeresco's CFO, Mark Chiplock, will resign effective September 25, 2026. The company's stock has declined 9.78% over five days and 17.60% year-to-date. Ameresco has received various ratings based on valuation, earnings revisions, and visibility.
1 min readAmeresco, Inc. (AMRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. amrc-20260817 FALSE 0001488139 0001488139 2026-07-22 2026-07-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):
1 min readAmeresco, Inc. announced that Mark A. Chiplock will resign as CFO, effective September 25, 2026, to pursue other opportunities. The company has started a search for a replacement. The departure is not due to any disagreement with the company.
1 min readAmeresco announced the departure of its Chief Financial Officer, according to a Reuters report. The company did not specify a reason for the departure or provide a successor. This leadership change may impact investor confidence and operational stability.
1 min readAmeresco, Inc. (AMRC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. amrc-20260817 FALSE 0001488139 0001488139 2026-07-22 2026-07-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):
1 min readU.S. industrial production rose 0.2% in July, below expectations of 0.4%, causing shares of Fluence Energy, Bloom Energy, Redwire, Ameresco, and GE Vernova to fall. Fluence Energy dropped 7.9%, Bloom Energy fell 11%, Redwire declined 5.2%, Ameresco fell 9.2%, and GE Vernova dropped 5.3%. Bloom Energy's volatility and recent price target hike by JPMorgan were also noted.
6 min readAmeresco's shares declined after Baird downgraded the company to 'Neutral' from 'Outperform' and reduced its price target to $32 from $36. The stock has fallen 10.56% over the past 5 days and 12.97% year-to-date.
1 min readAmaresco (AMRC) shares rose after its Neogenyx Fuels unit said it will join Adams Land & Cattle to break ground on a renewable natural gas facility in Broken Bow, Nebraska. The RNG project will use eight anaerobic digesters to produce over 4,400 SCFM of biogas, upgraded to about 1.2 million MMBtu/year of pipeline-quality RNG and avoid up to 63,700 metric tons of CO2 annually.
2 min read
